102
Views
1
CrossRef citations to date
0
Altmetric
Original Research

The Optimal Haemoglobin Target in Dialysis Patients May Be Determined by Its Contrasting Effects on Arterial Stiffness and Pressure Pulsatility

, , , & ORCID Icon
Pages 385-395 | Published online: 30 Dec 2020

References

  • Moody WE, Edwards NC, Chue CD, Ferro CJ, Townsend JN. Arterial disease in chronic kidney disease. Heart. 2013;99(6):365–372. doi:10.1136/heartjnl-2012-30281823118349
  • Zanoli L, Lentini P, Briet M, et al. Arterial stiffness in the heart of CKD. J Am Soc Nephrol. 2019;30(6):918–928. doi:10.1681/ASN.201902011731040188
  • London GM. Arterial stiffness in chronic kidney disease and end-stage renal disease. Blood Purif. 2018;45(1–3):154–158. doi:10.1159/00048514629478047
  • Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation. 2001;103(7):987–992. doi:10.1161/01.CIR.103.7.98711181474
  • Briet M, Boutouyrie P, Laurent S, London GM. Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int. 2012;82(4):388–400. doi:10.1038/ki.2012.13122534962
  • Fernandez-Fresnedo G, Rodrigo E, de Francisco ALM, de Castro SS, Castaneda O, Arias M. Role of pulse pressure on cardiovascular risk in chronic kidney disease patients. J Am Soc Nephrol. 2006;17:S246–S249.17130269
  • McIntyre NJ, Fluck RJ, McIntyre CW, Fakis A, Taal MW, Bochud M. Determinants of arterial stiffness in chronic kidney diseased stage 3. PLoS One. 2013;8(1):e55444. doi:10.1371/journal.pone.005544423383192
  • Major RW, Cheng MRI, Grant RA, et al. Cardiovascular disease risk factors in chronic kidney disease: a systematic review and meta-analysis. PLoS One. 2018;13:e0192895.29561894
  • Wyatt CM, Drueke TB. Higher hemoglobin levels and quality of life in patients with advanced chronic kidney disease: no longer a moving target? Kidney Int. 2016;89(5):971–975. doi:10.1016/j.kint.2016.03.00127083270
  • Kidney Disease: Improving. Global Outcomes (KDIGO) Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int. 2012;2(Suppl):279–335.
  • Phrommintikul A, Haas SJ, Elsik M, Krum H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet. 2007;369(9559):381–388. doi:10.1016/S0140-6736(07)60194-917276778
  • Palmer SC, Navaneethan SD, Craig JC, et al. Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Int Med. 2010;153(1):23–33. doi:10.7326/0003-4819-153-1-201007060-0025220439566
  • Wilkinson IB, Franklin SS, Cockcroft JR. Nitric oxide and the regulation of arterial stiffness. Hypertension. 2004;44(2):112–116. doi:10.1161/01.HYP.0000138068.03893.4015262901
  • Donadee C, Raat NJH, Kanias T, Tejero J, Lee JS, Kelly EE. Nitric oxide scavenging by red cell microparticles and cell-free haemoglobin as a mechanism for the red cell storage lesion. Circulation. 2011;124(4):465–476. doi:10.1161/CIRCULATIONAHA.110.00869821747051
  • Zhang -Z-Z, Wang P, Kong X-L, Mao W-L, Cui M-Y. Association of haemoglobin with arterial stiffness evaluated by carotid-femoral pulse wave velocity among Chinese adults. Chronic Dis Transl Med. 2018;5(2):122–128.31367701
  • Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Tatoh T. A slightly low haemoglobin level is beneficially associated with arterial stiffness in Japanese community-dwelling women. Clin Exp Hypertens. 2012;34(2):92–98. doi:10.3109/10641963.2011.61820221967025
  • Chen H, Hua Q, Hou H. Association of haemoglobin with ambulatory arterial stiffness index in untreated essential hypertensive patients without anemia. Intern Med. 2011;50(22):2759–2765. doi:10.2169/internalmedicine.50.583222082887
  • Lullo LD, Gorini A, Russo D, Santoboni A, Ronco C. Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment. Cardiorenal Med. 2015;5(4):254–266. doi:10.1159/00043583826648942
  • London GM, Gyerin AP, Marchais SJ, et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int. 1996;50(2):600–608. doi:10.1038/ki.1996.3558840292
  • Gunter S, Robinson C, Woodiwiss AJ, et al. Arterial wave reflection and subclinical atherosclerosis in rheumatoid arthritis. Clin Exp Rheumatol. 2018;36:412–420.29185969
  • Sahn DJ, DeMaria A, Kisslo J, Weyman A, American Society of echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58(6):1072–1083. doi:10.1161/01.CIR.58.6.1072709763
  • Townsend RR. Arterial stiffness and chronic kidney disease: lessons from the chronic renal insufficiency cohort study. Curr Opin Nephrol Hypertens. 2015;24:47–53.25470015
  • Feola M, Testa M, Ferreri C, Rosso GL, Rossi A, Ruocco G. The analysis of arterial stiffness in heart failure patients in comparison with healthy subjects with cardiovascular risk factors. J Clin Med. 2019;8(10):1721. doi:10.3390/jcm8101721
  • Liu M, Li G-L, Li Y, Wang J-G. Effects of various antihypertensive drugs on arterial stiffness and wave reflections. Pulse. 2013;1(2):97–107. doi:10.1159/00035410826587429
  • Scalera F, Kielstein JT, Martens-Lobenhoffer J, Postel SC, Tager M, Bode-Borger SM. Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase. Am J Soc Nephrol. 2005;16(4):892–898. doi:10.1681/ASN.2004090735
  • Esh H, Agabiti E, France MA, et al. 2018 ESC/ESH guidelines for the management of hypertension. Eur Heart J. 2018;39:3021–3104.30165516
  • Van Bortel LM, Laurent S, Boutouyrie P, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012;30(3):445–448. doi:10.1097/HJH.0b013e32834fa8b022278144
  • Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). J Hypertens. 2013;31:1281–1357.23817082
  • Fishbane S, Spinowitz B. Update on anemia in ESRD and earlier stages of CKD: core curriculum 2018. Am J Kidney Dis. 2018;71(3):423–435. doi:10.1053/j.ajkd.2017.09.02629336855
  • Fishbane S, Besarab A. Mechanisms of increased mortality risk with erythropoietin treatment to higher haemoglobin targets. Clin J Am Soc Nephrol. 2007;2(6):1274–1282. doi:10.2215/CJN.0238060717942772
  • Ni Z, Morcos S, Vaziri ND. Up-regulation of renal and vascular nitric oxide synthase in iron-deficiency anaemia. Kidney Int. 1997;52(1):195–201. doi:10.1038/ki.1997.3199211362
  • Metivier F, Marchais SJ, Guerin AP, Pannier B, London GM. Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transplant. 2000;15(suppl_3):14–18. doi:10.1093/oxfordjournals.ndt.a027970
  • Chirinos JA, Segers P, Hughes T, Townsend R. Large-artery stiffness in health and disease. State-of-the-art review. J Am Coll Cardiol. 2019;9(9):1237–1263. doi:10.1016/j.jacc.2019.07.012
  • Fazelli N, Hahan J-O. Estimation of cardiac output and peripheral resistance using square-wave-approximated aortic flow signal. Front Physiol. 2012;3:298.22934049
  • Papaioannou TG, Vardoulis O, Stergiopulos N. The systolic volume balance method for noninvasive estimation of cardiac output based on pressure wave analysis. Am J Physiol Heart Circ Physiol. 2012;302(10):H2064–H2073. doi:10.1152/ajpheart.00052.201222427512
  • Yoon H, Lee JH, Kim GS, et al. The relationship between anaemia and pulse pressure and hypertension: the Korea national health and nutrition examination survey 2010–2012. Clin Exp Hypertens. 2018;40(7):650–655. doi:10.1080/10641963.2017.141612329319360
  • Townsend RR, Chirinos JA, Parsa A, et al. Central pulse pressure in chronic kidney disease: a CRIC ancillary study. Hypertension. 2010;56(3):518–524. doi:10.1161/HYPERTENSIONAHA.110.15392420660819
  • Schwartz CP, Koppelstaetter C, Amann E, Mayer G. Impact of anemia on aortic pulse wave velocity in hemodialysis patients. Kidney Blood Press Res. 2009;32:210–216.19590228
  • Ferreira JP, Girerd N, Pannier B, Rossignol P, London GM. High pulse wave velocity defines a very high risk cohort of dialysis patients under age 60. Am J Nephrol. 2017;45(1):72–81. doi:10.1159/00045333827898419
  • Jones M, Ibels L, Schenkel B, Zagari M. Impact of epoetin alfa on clinical end points in patients with chronic renal failure. Kidney Int. 2004;65(3):757–767. doi:10.1111/j.1523-1755.2004.00450.x14871396
  • Weber T, Maas R, Auer J, et al. Arterial wave reflections and determinants of endothelial function. A hypothesis based on peripheral mode of action. Am J Hypertens. 2007;20(3):256–262. doi:10.1016/j.amjhyper.2006.09.00917324736